Our top pick for
AXIS Capital Holdings Limited is an insurance-property & casualty business based in the US. AXIS Capital shares (AXS) are listed on the NYSE and all prices are listed in US Dollars. AXIS Capital employs 1,921 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$52.34|
|52-week range||$41.39 - $58.12|
|50-day moving average||$47.87|
|200-day moving average||$51.12|
|Wall St. target price||$56.67|
|Dividend yield||$1.67 (3.27%)|
|Earnings per share (TTM)||$3.14|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||0.75%|
|1 month (2021-09-22)||15.49%|
|3 months (2021-07-22)||7.01%|
|6 months (2021-04-22)||-3.65%|
|1 year (2020-10-22)||10.33%|
|2 years (2019-10-22)||-16.34%|
|3 years (2018-10-22)||55.12|
|5 years (2016-10-21)||55.26|
Valuing AXIS Capital stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AXIS Capital's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AXIS Capital's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, AXIS Capital shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
AXIS Capital's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $588.3 million.
The EBITDA is a measure of a AXIS Capital's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$5.1 billion|
|Operating margin TTM||10.19%|
|Gross profit TTM||$636 million|
|Return on assets TTM||1.21%|
|Return on equity TTM||5.54%|
|Market capitalisation||$4.4 billion|
TTM: trailing 12 months
There are currently 770,454 AXIS Capital shares held short by investors – that's known as AXIS Capital's "short interest". This figure is 1.7% up from 757,326 last month.
There are a few different ways that this level of interest in shorting AXIS Capital shares can be evaluated.
AXIS Capital's "short interest ratio" (SIR) is the quantity of AXIS Capital shares currently shorted divided by the average quantity of AXIS Capital shares traded daily (recently around 554283.45323741). AXIS Capital's SIR currently stands at 1.39. In other words for every 100,000 AXIS Capital shares traded daily on the market, roughly 1390 shares are currently held short.
However AXIS Capital's short interest can also be evaluated against the total number of AXIS Capital shares, or, against the total number of tradable AXIS Capital shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AXIS Capital's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 AXIS Capital shares in existence, roughly 10 shares are currently held short) or 0.01% of the tradable shares (for every 100,000 tradable AXIS Capital shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AXIS Capital.
Find out more about how you can short AXIS Capital stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like AXIS Capital.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 33.01
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and AXIS Capital's overall score of 33.01 (as at 12/31/2018) is pretty weak – landing it in it in the 62nd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like AXIS Capital is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.16/100
AXIS Capital's environmental score of 1.16 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that AXIS Capital is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 11.47/100
AXIS Capital's social score of 11.47 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that AXIS Capital is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 14.38/100
AXIS Capital's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that AXIS Capital is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. AXIS Capital scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that AXIS Capital has, for the most part, managed to keep its nose clean.
|Total ESG score||33.01|
|Total ESG percentile||62.02|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||2|
Dividend payout ratio: 84% of net profits
Recently AXIS Capital has paid out, on average, around 84% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), AXIS Capital shareholders could enjoy a 3.23% return on their shares, in the form of dividend payments. In AXIS Capital's case, that would currently equate to about $1.67 per share.
AXIS Capital's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
AXIS Capital's most recent dividend payout was on 14 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 September 2021 (the "ex-dividend date").
AXIS Capital's shares were split on a 5:1 basis on 11 September 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your AXIS Capital shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for AXIS Capital shares which in turn could have impacted AXIS Capital's share price.
Over the last 12 months, AXIS Capital's shares have ranged in value from as little as $41.3885 up to $58.1235. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while AXIS Capital's is 0.918. This would suggest that AXIS Capital's shares are less volatile than average (for this exchange).
AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products worldwide. It operates through two segments, Insurance and Reinsurance. The Insurance segment offers property insurance products for commercial buildings, residential premises, construction projects, and onshore energy installations; marine insurance products covering offshore energy, cargo, liability, recreational marine, fine art, specie, and hull war; and terrorism, aviation, credit and political risk, and liability insurance products. It also provides professional insurance products that cover directors' and officers' liability, errors and omissions liability, employment practices liability, fiduciary liability, crime, professional indemnity, cyber and privacy, medical malpractice, and other financial insurance related coverages for commercial enterprises, financial institutions, not-for-profit organizations, and other professional service providers. In addition, this segment offers accidental death, travel, and specialty health products for employer and affinity groups. The Reinsurance segment offers reinsurance products to insurance companies, including catastrophe reinsurance products; property reinsurance products covering property damage and related losses resulting from natural and man-made perils; professional lines; credit and surety; and motor liability products. This segment also provides agriculture reinsurance products; coverages for various types of construction risks and risks related to erection, testing, and commissioning of machinery and plants during the construction stage; marine and aviation reinsurance products; and personal accident, specialty health, accidental death, travel, life and disability reinsurance products.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.